The global neuroprosthetics market size is expected to reach USD 61.84 billion by 2034, according to a new study by Polaris Market Research. The report “Neuroprosthetics Market Size, Share, Trends, Industry Analysis Report: By Type (Auditory Prosthetics/Cochlear Implants, Visual Prosthetics/Retinal Implants, Motor Prosthetics, and Cognitive Prosthetics), Technology, Application, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) – Market Forecast, 2025–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.
The neuroprosthetics market involves the development of implantable and wearable devices that interact with the nervous system to restore lost sensory, motor, or cognitive functions in individuals with neurological disorders or disabilities.
The neuroprosthetics market is experiencing growth due to increasing incidences of neurological conditions such as Parkinson’s disease, epilepsy, and spinal cord injuries, driving demand for advanced neurostimulation and brain-computer interface technologies. Technological advancements, including AI integration, miniaturization, and wireless connectivity, are enhancing device efficiency and patient outcomes.
Rising healthcare investments, favorable regulatory policies, and expanding applications in cognitive and motor disorders present significant neuroprosthetics market opportunities. Additionally, the growing focus on non-invasive neurostimulation and the increasing adoption of auditory and visual prosthetics support market growth.
Neuroprosthetics Market Report Highlights
In 2024, the spinal cord stimulation (SCS) segment led the market, driven by its extensive use in treating chronic pain, providing patients with substantial relief and enhancing their overall well-being.
By application, the motor neuron disorders segment held the largest market share in 2024, with increasing cases of conditions such as amyotrophic lateral sclerosis (ALS) and spinal cord injuries driving demand. Cognitive disorders is the fastest-growing segment, supported by rising research on neuroprosthetic applications for Alzheimer’s disease and depression.
North America led the market in 2024 due to high healthcare spending, advanced research, and strong adoption of neuroprosthetic devices. Asia Pacific is the fastest-growing region, driven by improving healthcare infrastructure, increasing neurological disorder cases, and rising investments in medical technology.
The neuroprosthetics market features several key players, including Abbott Laboratories; Blackrock Neurotech; Boston Scientific Corporation; BrainGate; Cochlear Limited; Kernel; LivaNova PLC; MED-EL; Medtronic plc; NeuroPace, Inc.; Paradromics; Precision Neuroscience; SensArs Neuroprosthetics; Sonova Holding AG; ans Synchron.
Polaris Market Research has segmented the neuroprosthetics market report on the basis of type, technology, application, and region:
By Type Outlook (Revenue – USD Billion, 2020–2034)
Auditory Prosthetics/Cochlear Implants
Visual Prosthetics/Retinal Implants
Motor Prosthetics
Cognitive Prosthetics
By Technology Outlook (Revenue – USD Billion, 2020–2034)
Spinal Cord Stimulation (SCS)
Vagus Nerve Stimulation (VNS)
Sacral Nerve Stimulation (SNS)
Deep Brain Stimulation (DBS)
By Application Outlook (Revenue – USD Billion, 2020–2034)
Cognitive Disorders
Motor Neuron Disorders
Physiological Disorders
By Regional Outlook (Revenue – USD Billion, 2020–2034)
North America
US
Canada
Europe
Germany
France
UK
Italy
Spain
Netherlands
Russia
Rest of Europe
Asia Pacific
China
Japan
India
Malaysia
South Korea
Indonesia
Australia
Vietnam
Rest of Asia Pacific
Middle East & Africa
Saudi Arabia
UAE
Israel
South Africa
Rest of Middle East & Africa
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook